Emirates airline boss sees positive progress at troubled Boeing
The head of the world's largest international airline, Dubai's Emirates, said on Sunday there were positive signs of progress at Boeing, having previously voiced frustration over delays in delivery of new jetliners from the planemaker.
Emirates President Tim Clark said he was seeing a greater degree of determination from Boeing to resolve its many issues under a recently appointed CEO, and management had indicated cautious optimism over its recovery in discussion with Emirates.
Boeing is trying to stabilize and ramp up production after a quality crisis and then labor strike shuttered production of most of its aircraft last year.
3 Emirates President Tim Clark said he was seeing greater determination from Boeing to resolve its issues.
AFP via Getty Images
Boeing is also awaiting certification from the US Federal Aviation Administration for its 777X wide-body plane, of which Emirates has 205 on order. Deliveries of the 777X are set to start in 2026, six years behind schedule.
Emirates has been told it could receive its first 777X any time between the second half of 2026 and the first quarter of 2027, Clark said, adding that he was sensing a more positive tone from Boeing on the plane's progress.
Boeing and European planemaker Airbus are months and years behind on new plane deliveries, frustrating airlines that want to upgrade to more fuel-efficient aircraft and launch new services.
Speaking at a news briefing on the sidelines of an International Air Transport Association summit, Clark said the industry was still facing chronic aerospace supply problems and challenged planemakers to take responsibility.
'I am pretty tired of seeing the hand-wringing about the supply chain: you (manufacturers) are the supply chain,' Clark said.
Last week, sources told Reuters that Airbus has been warning airlines it faces another three years of delivery delays in working through a backlog of supply-chain problems.
3 Boeing and competitor Airbus are months and years behind on new plane deliveries.
via REUTERS
Clark said the pandemic was no longer an acceptable excuse.
'It's a highly consolidated industry…I don't think they've managed to strip out the inefficiencies of the smaller units they brought together,' he said of the largest aerospace firms.
Emirates has not yet seen a shift in demand patterns as a result of President Trump's tariff war, Clark told an annual meeting of the IATA.
Clark said he expected U.S. manufacturer GE Aerospace, which makes engines for some of Emirates' planes, to absorb a lot of the impact from tariffs into its own margins.
3 Emirates has not seen a shift in demand due to President Trump's tariffs, according to the head of the carrier.
REUTERS
GE is Emirates' main engine supplier. It has said that it is passing along tariff costs to customers in the form of a surcharge.
Clark has previously expressed frustration with its other engine supplier, Britain's Rolls-Royce RR.L, because some engine models have struggled with maintenance problems when operating in the world's hottest climates.
On Sunday, Clark said opportunities still exist in the Gulf region for Rolls-Royce if it can deliver the required performance.
He left open whether a potential deal for Rolls-powered Airbus A350-1000 jets, which faltered over the durability of their engines at the Dubai Airshow in 2023, would be ready in time for the next edition in November this year.
'I am not sure about that,' he told reporters.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Investors bet on Trump tariff concessions as retaliation threats rattle markets
China shares rose while Europe and the U.S. slipped as investors bet—or at least hoped—that U.S. President Donald Trump would step back from his most recent aggressive tariff threats. S&P futures were off 0.4% while Hong Kong rose 1.5%. Are trade tensions rising or falling? Unable to answer that question, investors let markets slip in Europe and the U.S. on Tuesday morning, bumping China. U.S. President Donald Trump's recent doubling of steel and aluminum tariffs to 50% and the imposition of new limits on the sale of chip design software to China—as well as his claim that Beijing had 'totally violated' the terms of the U.S.-China tariff truce—did little to encourage investors. Nor did EU threats of retaliation against the metals tariffs, as well as China's veiled warning that it would 'continue to take resolute and forceful measures to safeguard its legitimate rights and interests.' Still, investor sentiment that Trump's tariff threats are not as dire as they first appear and that his administration will end up backing off the toughest ones (aka the 'TACO' trade) seems to be cushioning the markets from further drops. 'Reports in Washington suggest US President Trump may talk directly with China's President Xi later this week (after several days of more heated rhetoric between the US and China over trade),' UBS chief economist Paul Donovan said in a Tuesday note. 'As Trump has been anxious for the call, and China has not, this may hint at more US retreats over trade taxes as a concession to bring China to the telephone.' European markets and U.S. futures were down slightly early Tuesday, with the Stoxx Euro 600 dropping 0.2% while S&P futures were off 0.4% before the opening bell. In Asia, markets in China rose: Shanghai rose 0.4% after Monday's holiday, while Hong Kong's Hang Seng jumped 1.5%. 'It's a difficult time to forecast right now given the relentless crossfire of trade headlines. But there's a growing sense that we're now on a turbulent but sustained path towards de-escalation,' wrote Deutsche Bank's global head of macro research Jim Reid. 'Even if the US administration remain hawkish on trade, we have already seen there are limits to that approach, particularly in the face of market turmoil and declining approval ratings for President Trump. Here's a snapshot of today's action prior to the opening bell in New York (6:15 a.m. ET): • The S&P 500 was up 0.4% Monday. The index is up 0.9% YTD.• S&P futures were trading down 0.5% this morning.• The Stoxx Europe 600 was down 0.2% in early trading.• Asia was mixed: Japan was off 0.1%. Hong Kong rose 1.5%. Shanghai was up 0.4%, and India's Nifty 50 was off 0.7%.• Bitcoin was sitting up at $105,300 this morning. This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
25 minutes ago
- Business Wire
One Year in, Mastercard's Checkout Transformation Gains Ground Across Europe
AMSTERDAM--(BUSINESS WIRE)--One year after announcing its vision to phase out manual card entry and drive 100% tokenisation, Mastercard is celebrating major strides across Europe, where a growing number of partners are adopting the technologies that underpin safer, smarter digital commerce. Nearly half of Mastercard e-commerce transactions are now tokenised in Europe. These tokenised transactions, including Secure Card on File (SCOF), Click to Pay, and digital wallets, have increased by over one third in the past year. Merchant tokenisation, known as Secure Card on File (SCOF), is now live in 45 European countries and territories, helping reduce fraud and improve approval rates by replacing card numbers with dynamic, merchant-specific tokens. Click to Pay has expanded to 26 European markets, and enrolments have more than doubled over the past year, streamlining checkout for even more returning users. Meanwhile, payment passkeys are emerging as a breakthrough in digital authentication, allowing users to authenticate with a fingerprint or facial recognition- eliminating passwords. Newly onboarded partners working with Mastercard to accelerate adoption of seamless, secure digital checkout over the past 12 months include: Tokenisation: Delivery Hero (eFood, Foody, Foodora, and Glovo), Global Collect (Worldline), Monext, Santander Click to Pay: Autopay, Consors Finanz BNP Paribas, Fiserv, ICA Banken, Lendable, Nickel, N26, Ogone (Worldline), PayU, SaferPay (Worldline), SIX, and tPay Payment passkeys: Dintero, Netopia, Solidgate 'One year into our 100% tokenisation and authentication journey, Europe is gaining strong momentum,' said Brice van de Walle, Executive Vice President, Core Payments Europe, Mastercard. 'We're working with partners to make digital payments more secure and seamless, through Click to Pay, passkeys, and tokens.' Mastercard research 1 shows that 54% of Europeans feel irritated when asked to create an account at checkout, and 82% report some level of frustration navigating friction-heavy processes. By replacing passwords with passkeys, securely auto filling card details, and using encrypted tokens, Mastercard and its partners are addressing these pain points, making checkout safer and more user-friendly. 'We want to offer the best and most secure payment alternatives to our customers,' said Matias Sanchez, Global Head of Cards and Digital Solutions at Santander. 'With tokenisation, their card details are better protected, making checkout easier, faster, and more secure. Partnering with Mastercard allows us to bring this extra layer of safety, therefore Click to Pay is one of our top priorities.' "Mastercard Payment Passkeys mark a major step toward secure, seamless, and user-friendly digital payments. As the first European processor to combine this with Click to Pay, we're proud to offer a faster, safer, password-free experience, setting a new standard for digital commerce and building on our strong partnership with Mastercard," said Marius Costin, Chief Executive Officer, NETOPIA Payments. Mastercard will continue partnering across the region to expand access, raise consumer awareness, and accelerate adoption, advancing its path toward 100% tokenisation and authentication by 2030. 1 Mastercard nationally representative survey of 18,000 consumers aged 18+ across 12 European countries conducted by 3Gem – between 26th November and 3rd December 2024. *Almost half of Mastercard switched card not present transactions in April 2025 were tokenised. About Mastercard (NYSE: MA) Mastercard powers economies and empowers people in 200+ countries and territories worldwide. Together with our customers, we're building a resilient economy where everyone can prosper. We support a wide range of digital payments choices, making transactions secure, simple, smart and accessible. Our technology and innovation, partnerships and networks combine to deliver a unique set of products and services that help people, businesses and governments realize their greatest potential.
Business Wire
26 minutes ago
- Business Wire
MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies
MUNICH--(BUSINESS WIRE)-- MarkHerz Inc., a biotechnology company specializing in AAV-based gene therapies targeting cardiovascular and metabolic diseases, announced that it has signed a Memorandum of Understanding (MOU) on May 16, 2025 with Klinikum rechts der Isar, the university hospital affiliated with the Technical University of Munich (TUM), Germany. 'This partnership goes beyond R&D it marks the beginning of international clinical and commercial deployment of our platform technology.' The agreement aims to establish a broad-based collaboration on the joint research and development of next-generation gene therapies for ischemic heart and peripheral vascular diseases. This will center around MarkHerz's proprietary MAAV Platform, which enables the development of precision-targeted AAV gene therapies, particularly its MRTF-A candidate. The collaboration will include preclinical and clinical trials, technology consulting, and the sharing of research infrastructure. The signing ceremony was attended by leading cardiovascular gene therapy expert Prof. Christian Kupatt (MD, TUM), patent attorney Dr. Rudolph Schön of Germany's Neymeyr & Partner, Seungmin Lee (Dr. Mark Lee), CEO of MarkHerz, and Jeongseo Baek (Grace Baek), Head of the company's German office. Building a Strategic Gateway into the European Clinical Landscape MarkHerz's entry into Germany reflects a strategic initiative to complement Korea's increasingly regulated domestic environment by leveraging Europe's flexible clinical trial pathways, such as EMA's Early Access programs and Investigator-Initiated Trials. TUM Hospital's extensive cardiovascular preclinical models and translational research capacity are expected to generate high-quality data recognized by global regulatory agencies, including the EMA, FDA, PMDA, and MFDS. Dr. Seungmin Lee emphasized, 'The clinical validation of cardiovascular gene therapies is a critical factor in licensing negotiations with global pharma partners. This partnership goes beyond R&D it marks the beginning of international clinical and commercial deployment of our platform technology.' MRTF-A gene therapy: expanding the horizons of regenerative medicine MarkHerz's MRTF-A treatment aims to overcome the limitations of existing protein-based treatments, such as VEGF and FGF, by promoting functional blood vessel regeneration through endothelial recovery. This treatment is designed to deliver long-term efficacy in a single dose while addressing the core promise of gene therapy: sustained, one-time treatment. The company's vector innovations using AAV9, AAVrh74 and AAV-LK03, optimized for specific organ targeting, establish a platform for expansion beyond rare diseases into cardiovascular and neurological diseases, aligning with global trends and further validating the scalability of the technology. Deepening Ties with Europe's Leading Research Ecosystem This agreement positions MarkHerz to strengthen ties with not only TUM, but also Ludwig Maximilian University (LMU) Munich and the BioM Cluster, forming a robust network across Europe's premier scientific institutions. These partners represent the heart of Europe's innovation engine, together having produced more than 50 Nobel laureates and offer broad potential for collaboration across biotechnology, neuroscience, and translational medicine. Dr. Rudolph Schön noted, 'Successful gene therapy commercialization in Europe requires a seamless integration of regulation, technology, and strategic partnerships. This MOU represents a vital first step.' Prof. Kupatt added, 'This agreement is a turning point, translating years of research into clinical and commercial reality.' A Global Bridge Strategy Beyond Borders MarkHerz is pursuing a 'global bridge' strategy that aims not only to transfer technology or engage in joint research, but to actively overcome structural barriers in Korea's biotech ecosystem, such as regulatory bottlenecks, limited venture investment, and a high reliance on large conglomerates. 'Korea's biotech sector is rapidly growing but still faces fundamental challenges,' said Dr. Seungmin Lee. 'Through this Korea-Germany partnership, MarkHerz aims to lead by example and establish a new model for successful global clinical and commercial integration.' MarkHerz currently collaborates with over 250 partner institutions and, through formal alliances with 15 of them, operates eight distinct pipelines. Notably, active joint research projects valued at approximately KRW 15 billion are underway in AAV-based cardiovascular therapies (licensed in 10 European countries), diabetes treatments, cerebrovascular disorder therapies and CAR-Treg–based cancer immunotherapies.
